Cost-effectiveness analysis and budgetary impact of antipsychotics available in the Brazilian Unified Health System
J. bras. econ. saúde (Impr.); 12 (3), 2020
Objective: To carry out a cost-effectiveness and budget impact analysis of antipsychotic use in adults to treat schizophrenia from the perspective of the Unified Health System (SUS). Methods: A Markov model simulated the treatment of schizophrenic patients with an initial average age of 25 years and a li...
